| Literature DB >> 23928248 |
Savannah C Partridge1, Elizabeth S McDonald.
Abstract
Diffusion-weighted magnetic resonance (MR) imaging (DWI) has shown promise for improving the positive predictive value of breast MR imaging for detection of breast cancer, evaluating tumor response to neoadjuvant chemotherapy, and as a noncontrast alternative to MR imaging in screening for breast cancer. However, data quality varies widely. Before implementing DWI into clinical practice, one must understand the pertinent technical considerations and current evidence regarding clinical applications of breast DWI. This article provides an overview of basic principles of DWI, optimization of breast DWI protocols, imaging features of benign and malignant breast lesions, promising clinical applications, and potential future directions.Entities:
Keywords: Apparent diffusion coefficient; Breast MR imaging; Breast cancer; Diffusion-weighted imaging; Neoadjuvant chemotherapy; Oncologic imaging; b-value
Mesh:
Year: 2013 PMID: 23928248 PMCID: PMC3740446 DOI: 10.1016/j.mric.2013.04.007
Source DB: PubMed Journal: Magn Reson Imaging Clin N Am ISSN: 1064-9689 Impact factor: 2.266